Page last updated: 2024-10-26

dipyridamole and Neutropenia

dipyridamole has been researched along with Neutropenia in 2 studies

Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.

Neutropenia: A decrease in the number of NEUTROPHILS found in the blood.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, P1
Chien, PY1
Khan, AR1
Sheikh, S1
Ali, SM1
Ahmad, MU1
Ahmad, I1
Diener, HC1

Reviews

1 review available for dipyridamole and Neutropenia

ArticleYear
Stroke prevention: antiplatelet and antithrombolytic therapy.
    Haemostasis, 2000, Volume: 30 Suppl 3

    Topics: Anticoagulants; Aspirin; Brain Damage, Chronic; Carotid Stenosis; Clinical Trials as Topic; Clopidog

2000

Other Studies

1 other study available for dipyridamole and Neutropenia

ArticleYear
In-vitro and in-vivo anti-cancer activity of a novel gemcitabine-cardiolipin conjugate.
    Anti-cancer drugs, 2006, Volume: 17, Issue:1

    Topics: Animals; Antineoplastic Agents; Body Weight; Cardiolipins; Cell Proliferation; Deoxycytidine; Dipyri

2006